Food prices could rise as Iran conflict disrupts fertilizer supply chain
The Iran conflict is disrupting fertilizer shipments through the Strait of Hormuz, raising supply concerns and potentially increasing global food inflation....
Category : Business
JPMorgan Chase reins in lending to private credit firms after marking down software loans
JPMorgan’s move shows that the biggest U.S. bank by assets wants to get ahead of potential turbulence involving private credit loans to software companies....
Ford launches new AI to grow multibillion-dollar Pro commercial business
Ford CEO Jim Farley last month said diversifying Pro’s revenue — specifically in software — is a crucial growth area for the company....
February home sales see small rebound, but supply growth is ‘sluggish’
Home sales made a small gain to start the year, but higher mortgage rates now could throw cold water on the spring season....
FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism treatment
The move comes months after the Trump administration touted leucovorin as a potential therapy for a broader group of patients with autism symptoms....
Fabletics bets big on denim launch as athleisure boom fades
Fabletics is launching a new denim assortment priced between $79.95 and $174.95 as the athleisure boom starts to slow down....
Ticketmaster parent Live Nation reaches settlement with Department of Justice over antitrust concerns
Live Nation, which owns Ticketmaster, reached a settlement with the Department of Justice over antitrust concerns....
Inside the booming business of wellness third spaces and membership clubs
A growing number of consumers are seeking out third spaces and membership clubs surrounding wellness, to improve their health while also socializing....
FDA vaccine head will step down in April after string of controversial decisions
Vinay Prasad is leaving his post as director of the Center for Biologics Evaluation and Research....
FDA reversals leave investors worrying about the fates of other experimental drugs
Investors are scrutinizing the prospects for some drugs in the pipeline following a string of recent rejections from the U.S. Food and Drug Administration. ...